7447-41-8

• 常用中文名：IC 锂标准品
• 常用英文名：Lithium chloride
• CAS号：7447-41-8
• 分子式：ClLi
• 分子量：42.39400
• 相关类别： 无机化工 无机盐 金属卤化物及卤酸盐 金属氯化物及盐
• 发布时间：2018-02-08 08:00:00
• 更新时间：2026-06-30 07:34:53
• 用于空气调节、烟火、干电池及制金属锂，也用作助焊剂、干燥剂

名称

• 中文名: 氯化锂
• 英文名: lithium chloride
• 中文别名: 氯化锂4N; 氯化锂,超干; 氯化锂(的四氢呋喃溶液,.5MOL/L); 氯化锂,特级品; 氯化锂 最低; LITHIUM CHLORIDE ( IN TETRAHYDROFURAN, CA. 0.5MOL/L) 氯化锂(的四氢呋喃溶液,.5MOL/L); 乙酰基环己烷/1-Cyclohexylethan-1-one; 氯化锂-乙醇滴定溶液标准物质; 电解液 溶液; 氯化锂(无水)99; 氯化锂 MIN; 锂原子光谱分析标准浓缩液 1.00G LI; 无水氯化锂, MIN; 无水氯化锂 氯化锂基地; 进口无水氯化锂; 氯化锂, 无水; 氯化锂 溶液; 氯化锂 无水氯化锂; 氯化锂(无水)-特规; 高纯氯化锂; 氯化锂,无水级, (AT); 氯化锂(粉末); LITHIUM CHLORIDE 无水氯化锂; LITHIUM CHLORIDE SOLUTION(氯化锂溶液),4M; 氯化锂/无水氯化锂; LITHIUM CHLORIDE,GSK3BETA抑制剂; 氯化锂, 超干; 无水氯化锂(7-8); 氯化锂无水物; 天齐颗粒99氯化锂; 氯化锂,超干,无水; 氯化锂溶液, 0.5 M 无水四氢呋喃溶液, J&KSEAL瓶; 氯化锂单水合物; 无水氯化锂; 氯化锂,无水; 氯化锂(分子生物学级); 氯化锂(结晶); 氯化锂 7-8; 氯化锂(无水); 超干氯化锂
• 英文别名: LITHIUMCHLORIDE,CRYSTAL; Lithium chloride, anhydrous, min; LITHIUM ION; LITHIUM, ION CHROMATOAPHY STANDD SOLUTION; Lithium chloride anhydrous, free-flowing, Redi-Dri(TM), ReagentPlus(R); LITHIUMCHLORIDE,POWDER; LithiuM Chloride; LITHIUM CHLORIDE, ANHYDROUS, BEADS, -10 MESH; LITHIUM CHLORIDE EXTRA; Lithium chloride anhydrous, beads, -10 mesh, trace; LITHIUM CHLORIDE SOLUTION, 1 M IN GLACIA L ACETIC ACID; LITHIUM CHLORIDE REAGENTPLUS(TM); J-7447; Lithium chloride Vetec(TM) ade; Anhydrous lithiuM chloride; LITHIUM ION CHROMATOAPHY STANDD; lithium atomic spectroscopy standd concentrate 1. li; LITHIUM ATOMIC SPECTROSCOPY STD. CONC. 1 . LI, AMPOULE; LITHIUM CHLORIDE FOR ANALYSIS EMSURE; Lithium chloride . p.a., anhydrous, >= (AT); Lithium Chloride, MB ade (1.05673); Lithium chloride, anhydrous, beads, #10 mesh; Lithium chloride, anhydrous; lithium,chloride; LITHIUM ION STANDD; Lithium chloride solution 0.5 M in anhydrous tetrahydrofuran; Lithium chloride , >=; lithium chloride, ultra dry; LithiuM chloride powder, >= trace Metals basis; LITHIUM CHLORIDE ANHYDROUS, LOW INSODIUM; ( in Tetrahydrofuran, ca. 0.5Mol/L); Lithiumchloride,anhydrous; Additive Screening Solution 15/Fluka kit no 78374, Lithium chloride solution; LITHIUM CHLORIDE, ANUL; Lithium chloride, MoleculBiology ade; lithium ion standd solution; Lithium chloride solution; LITHIUM CHLORIDE SOL., F. MOL. BIOL., 8 M IN WATER; Lithium, Ion chromatoaphy standd solution, Speure(R), Li- 1000μg/ml; Lithium chloride ReagentPlus(R); LITHIUM CHLORIDE MOLECULBIOLOGY*REAGE NT; LITHIUM CHLORIDE ANHYDROUS, FOR MOLECULA R BIOLOGY; EINECS 231-212-3; LithiuM chloride anhydrous, beads, -10 Mesh, >= trace Metals basis; LITHIUM CHLORIDE PURIFIED; LITHIUM ION STANDD SOLUTION FLUKA, FOR ISE, 0.01 M; LITHIUM CHLORIDE ANYD; Lithium Chloride ( in Tetrahydrofuran, ca. 0.5mol/L); LITHIUM CHLORIDE SOLUTION, 1 M IN ETHANO L; Lithium chloride anhydrous, free-flowing, Redi-Dri(TM) >=; LithiuM chloride, for Moleculbiology; LITHIUM CHLORIDE ANHYDROUS extrapure; MFCD00064606; LITHIUM CHLORIDE ANHYDROUS; Lithium Ion standd solution Fluka; LITHIUM CHLORIDE, REAGENTPLUS; Lithiumchlorid

物化性质

• 密度: 2.06
• 沸点: 1382°C
• 熔点: 605 °C(lit.)
• 分子式: ClLi
• 分子量: 42.39400
• 闪点: -4 °F
• 精确质量: 41.98490
• 外观性状: 白色无臭固体
• 折射率: n20/D 1.381
• 储存条件:

  应贮存在阴凉、通风、干燥的库房内。

• 稳定性:

  溶于水、乙醇、丙酮、氨水。水溶液呈中性或微碱性。易潮解，在100g水中的溶解度为67g（0℃）、127.5g(100℃)。可溶于乙醇、丙酮、吡啶等有机溶剂。注意密封保存。

• 水溶解性: 832 g/L (20 ºC)
• 分子结构:

  1、 摩尔折射率：无可用

  2、 摩尔体积（cm³/mol）：无可用

  3、 等张比容（90.2K）：无可用

  4、 表面张力（dyne/cm）：无可用

  5、 极化率：无可用

• 计算化学:

  1.疏水参数计算参考值（XlogP）:无

  2.氢键供体数量:0

  3.氢键受体数量:1

  4.可旋转化学键数量:0

  5.互变异构体数量:无

  6.拓扑分子极性表面积0

  7.重原子数量:2

  8.表面电荷:0

  9.复杂度:2

  10.同位素原子数量:0

  11.确定原子立构中心数量:0

  12.不确定原子立构中心数量:0

  13.确定化学键立构中心数量:0

  14.不确定化学键立构中心数量:0

  15.共价键单元数量:2

• 更多:

  1. 性状：白色立方结晶或粉末。易潮解。

  2. 密度（g/mL,25/4℃）： 2.07

  3. 熔点（ºC）：614

  4. 沸点（ºC,常压）：1357

  5. 折射率： 1.381

  6. 溶解性：溶于乙醇、醚、吡啶、戊醇和丙酮

MSDS

第一部分：化学品名称 化学品中文名称: 氯化锂 化学品英文名称: Lithium chloride CAS No.: 7447-41-8 分子式: LiCl 分子量: 42.39 第二部分：成分/组成信息 化学品名称：氯化锂 有害物成分: 氯化锂 含量: 无资料 CAS No.: 7447-41-8 第三部分：危险性概述 侵入途径: 吸入 食入 经皮吸收 健康危害: 本品属低毒类。对眼睛和粘膜具有强烈的刺激和腐蚀作用。中毒主要由于误服，病人出现全身，无力、眩晕、耳鸣、视力模糊、口干、食欲减退、恶心、呕吐或腹泻。重者出现抽搐、昏迷，有时可呈现精神障碍。 环境危害: 对环境可能有危害，对水体可造成污染 燃爆危险: 本品不燃，遇明火、高热可燃。其粉体与空气可形成爆炸性混合物, 当达到一定浓度时, 遇火星会发生爆炸。受高热分解放出有毒的气体。 第四部分：急救措施 皮肤接触: 用流动清水冲洗，若有灼伤，按碱灼伤处理。立即脱去污染的衣着，用大量流动清水冲洗。就医。 眼睛接触: 拉开眼睑，用流动清水冲洗15分钟。就医。 吸入: 迅速脱离现场至空气新鲜处。保持呼吸道通畅。如呼吸困难，给输氧。如呼吸停止，立即进行人工呼吸。就医。 食入: 误服者，口服牛奶、豆浆或蛋清，就医。饮足量温水，催吐。就医。 第五部分：消防措施 危险特性: 与三氟化溴发生剧烈反应。受高热分解，放出有毒的烟气。能与氧化物反应，呈强还原性。受高热分解放出有毒的气体。 有害燃烧产物: 能与氧化物反应，呈强还原性。受高热分解放出有毒的气体。 灭火方法及灭火剂: 不燃。消防人员必须穿全身防火防毒服，在上风向灭火。灭火时尽可能将容器从火场移至空旷处。然后根据着火原因选择适当灭火剂灭火。 消防员的个体防护: 全身防火防毒服 第六部分：泄漏应急处理 应急处理: 隔离泄漏污染区，周围设警告标志，建议应急处理人员戴好防毒面具，穿化学防护服。小心扫起，装入备用袋中。也可以用大量水冲洗，经稀释的污水放入废水系统。如大量泄漏，收集回收或无害处理后废弃。 第七部分：操作处置与储存 操作注意事项: 密闭操作，提供充分的局部排风。防止粉尘释放到车间空气中。操作人员必须经过专门培训，严格遵守操作规程。建议操作人员佩戴防尘面具（全面罩），穿胶布防毒衣，戴橡胶手套。避免产生粉尘。避免与氧化剂、酸类接触。配备泄漏应急处理设备。倒空的容器可能残留有害物。 储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。防止阳光直射。包装密封。应与氧化剂、酸类分开存放，切忌混储。储区应备有合适的材料收容泄漏物。 第八部分：接触控制/个体防护 最高容许浓度: 中 国 MAC：未制订标准前苏联 MAC：未制订标准美国TLV—TWA：未制订标准 工程控制: 密闭操作，局部排风。严加密闭，提供充分的局部排风。 呼吸系统防护: 可能接触其蒸气时，应该佩戴防毒口罩。可能接触其粉尘时，必须佩戴防尘面具（全面罩）。紧急事态抢救或撤离时，应该佩戴空气呼吸器。 眼睛防护: 戴化学安全防护眼镜。呼吸系统防护中已作防护。 身体防护: 穿防腐工作服。穿胶布防毒衣。 手防护: 戴橡胶手套。 其他防护: 工作现场禁止吸烟、进食和饮水。工作后，淋浴更衣。注意个人清洁卫生。 第九部分：理化特性 外观与性状: 无色立方晶体，具有潮解性。 熔点(℃): 605 沸点(℃): 1350 相对密度(水=1): 2．068(25℃) 饱和蒸气压(kPa): 0．133／547℃ 分子式: LiCl 分子量: 42.39 溶解性: 易溶于水、乙醇、乙醚。 主要用途: 用于空气调节，用作助焊剂、干燥剂、化学试剂，并用于制焰火、干电池和金属锂等。 第十部分：稳定性和反应活性 稳定性: 在常温常压下 稳定 禁配物: 强氧化剂、强酸。 避免接触的条件: 接触潮湿空气。 聚合危害: 不能出现 分解产物: 氯化氢。 第十一部分：毒理学资料 急性毒性: LD50：526mg／kg(大鼠经口) LC50： 刺激性: 家兔经皮：500mg/24小时，重度刺激。家兔经眼： 100mg/24 小时，中度刺激。 第十三部分：废弃处置 废弃处置方法: 用安全掩埋法处置。在能利用的地方重复使用容器或在规定场所掩埋。量小时，中和本品的水溶液，滤出固体做掩埋处置，溶液冲入下水道。反应产生热和烟雾，通过控制加入速度予以控制。 第十五部分：法规信息 国内化学品安全管理法规: 化学危险物品安全管理条例 (1987年2月17日国务院发布)，化学危险物品安全管理条例实施细则 (化劳发[1992] 677号)，工作场所安全使用化学品规定 ([1996]劳部发423号)等法规，针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定。 第十六部分：其他信息 参考文献: 1.周国泰，化学危险品安全技术全书，化学工业出版社，1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编，化学品毒性法规环境数据手册，中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989 填表时间: 年月日 其他信息: 5 MSDS修改日期: 年月日

毒性和生态

毒理学数据: 1 、 试验方法：皮下 摄入剂量：1240毫克/千克，女性12月13日一天（县）后受孕 测试对象：啮齿动物-鼠 毒性类型：生殖 毒性作用：颅面（包括鼻子和舌头）发展异常 2、 试验方法：行政上的皮肤 摄入剂量：500 mg/24H 测试对象：啮齿动物-兔 毒性类型：SkinEyeIrrition 毒性作用：剧烈反应 3 、 试验方法：行政到眼睛 摄入剂量：100 mg/24H 测试对象：啮齿动物-兔 毒性类型：SkinEyeIrrition 毒性作用：1.较稳定 4 、 试验方法：腹腔 摄入剂量：882 mg/kg/7D-I 测试对象：啮齿动物-鼠 毒性类型：瘤 毒性作用：1.肿瘤的RTECS标准 2.淋巴瘤，包括霍奇金病 生态学数据: 该物质对环境可能有危害，对水体应给予特别注意。 CHEMICAL IDENTIFICATION RTECS NUMBER : OJ5950000 CHEMICAL NAME : Lithium chloride CAS REGISTRY NUMBER : 7447-41-8 LAST UPDATED : 199701 DATA ITEMS CITED : 51 MOLECULAR FORMULA : Cl-Li MOLECULAR WEIGHT : 42.39 WISWESSER LINE NOTATION : LI G HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : Standard Draize test ROUTE OF EXPOSURE : Administration onto the skin SPECIES OBSERVED : Rodent - rabbit TYPE OF TEST : Standard Draize test ROUTE OF EXPOSURE : Administration into the eye SPECIES OBSERVED : Rodent - rabbit TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human DOSE/DURATION : 200 mg/kg/3D TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - muscle weakness Behavioral - muscle contraction or spasticity TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Human DOSE/DURATION : 243 mg/kg/13D TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - tremor Gastrointestinal - nausea or vomiting TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 526 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 514 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 499 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intracerebral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 4800 ug/kg TOXIC EFFECTS : Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity) Nutritional and Gross Metabolic - body temperature decrease TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1165 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 600 mg/kg TOXIC EFFECTS : Nutritional and Gross Metabolic - body temperature decrease TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 738 mg/kg TOXIC EFFECTS : Behavioral - tremor Musculoskeletal - other changes TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 363 mg/kg TOXIC EFFECTS : Brain and Coverings - recordings from specific areas of CNS Behavioral - antipsychotic TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intracerebral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 14040 ug/kg TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - ptosis Behavioral - somnolence (general depressed activity) TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 500 mg/kg TOXIC EFFECTS : Behavioral - food intake (animal) Gastrointestinal - changes in structure or function of salivary glands Musculoskeletal - other changes TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Mammal - cat DOSE/DURATION : 492 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Mammal - cat DOSE/DURATION : 450 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 800 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 531 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 620 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Bird - pigeon DOSE/DURATION : 513 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Bird - quail DOSE/DURATION : 422 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Amphibian - frog DOSE/DURATION : 885 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Bird - wild bird species DOSE/DURATION : 422 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 712 mg/kg/1W-C TOXIC EFFECTS : Behavioral - fluid intake Nutritional and Gross Metabolic - weight loss or decreased weight gain TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 500 mg/kg/10D-I TOXIC EFFECTS : Liver - changes in liver weight Kidney, Ureter, Bladder - urine volume increased Endocrine - changes in spleen weight TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 678 mg/kg/8D-I TOXIC EFFECTS : Behavioral - fluid intake Kidney, Ureter, Bladder - urine volume increased Kidney, Ureter, Bladder - other changes in urine composition TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 5440 mg/kg/17D-I TOXIC EFFECTS : Kidney, Ureter, Bladder - other changes in urine composition Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 4200 mg/kg/42D-I TOXIC EFFECTS : Behavioral - coma Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 882 mg/kg/7D-I TOXIC EFFECTS : Tumorigenic - neoplastic by RTECS criteria Blood - lymphoma, including Hodgkin's disease TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 41360 mg/kg SEX/DURATION : male 1 day(s) pre-mating TOXIC EFFECTS : Reproductive - Fertility - mating performance (e.g. # sperm positive females per # females mated; # copulations per # estrus cycles) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 809 mg/kg SEX/DURATION : female 9-16 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Effects on Embryo or Fetus - other effects to embryo TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 979 mg/kg SEX/DURATION : female 7-16 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 1 gm/kg SEX/DURATION : female 7-11 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - abortion Reproductive - Effects on Embryo or Fetus - fetal death TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 1250 mg/kg SEX/DURATION : female 7-11 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous DOSE : 28 mg/kg SEX/DURATION : male 14 day(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - other effects on male Endocrine - changes in luteinizing hormone Endocrine - androgenic TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous DOSE : 42 mg/kg SEX/DURATION : male 21 day(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 66 gm/kg SEX/DURATION : female 1-21 day(s) after conception lactating female 21 day(s) post-birth TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Effects on Newborn - biochemical and metabolic Reproductive - Effects on Newborn - physical TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 475 mg/kg SEX/DURATION : male 7 day(s) pre-mating female 7 day(s) pre-mating - 21 day(s) post-birth TOXIC EFFECTS : Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) Reproductive - Effects on Newborn - biochemical and metabolic Reproductive - Effects on Newborn - physical TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 320 mg/kg SEX/DURATION : female 6-7 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Newborn - other neonatal measures or effects TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous DOSE : 1240 mg/kg SEX/DURATION : female 12-13 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) TYPE OF TEST : Cytogenetic analysis MUTATION DATA TEST SYSTEM : Rodent - mouse DOSE/DURATION : 21 mg/kg/3D (Intermittent) REFERENCE : CYTOAN Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929- Volume(issue)/page/year: 54,245,1989 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84472 No. of Facilities: 1089 (estimated) No. of Industries: 26 No. of Occupations: 25 No. of Employees: 5881 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84472 No. of Facilities: 2291 (estimated) No. of Industries: 36 No. of Occupations: 36 No. of Employees: 34091 (estimated) No. of Female Employees: 15304 (estimated)

安全

• 符号: GHS02, GHS07, GHS08
• 信号词: Danger
• 危害声明: H225-H302-H319-H335-H351
• 补充危害声明: May form explosive peroxides.
• 警示性声明: P210-P280-P301 + P312 + P330-P305 + P351 + P338-P370 + P378-P403 + P235
• 个人防护装备: Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
• 危害码 (欧洲): Xn:Harmful
• 风险声明 (欧洲): R22;R36/38
• 安全声明 (欧洲): S26-S37/39-S36/37/39-S16-S36-S45-S33-S29
• 危险品运输编码: UN 2789 8/PG 2
• WGK德国: 1
• RTECS号: OJ5950000
• 包装等级: III
• 危险类别: 8
• 海关编码: 2827391000

制备

1.盐酸法 将盐酸加入反应器中，将碳酸锂按稍过于理论量缓慢加入进行反应，生成氯化锂，经过滤后，将滤液蒸发浓缩析出结晶，再经冷却、迅速抽滤，制得无水氯化锂成品。其反应方程式如下：

2.将碳酸锂溶于盐酸中，蒸干，即可制得氯化锂的白色粉末。

为了制得特别纯的无水氯化锂，必须精制提纯。精制方法有三：（1）经碳酸盐进行精制；（2）使氟化锂沉淀后转变成氯化锂；（3）采用离子交换树脂进行精制。现将（3）法择要介绍如下：

阳离子交换树脂采用Amberlite IR120氢型树脂，容量100mL；阴离子交换树脂采用Amberlite IRA400氯型树脂，容量100mL。将氯化锂溶于25%（摩尔分数）甲醇一水混合溶剂中制成氯离子浓度在1mol/L以下的原液，也可用25%（体积分数）甲醇的05mol/L盐酸作为洗提液，可在室温下操作。此方法可除去难以除去的钙离子和70%硫酸根离子，得到纯氯化锂。此法简单、迅速。

海关

海关编码	2827391000